Evidence map›Paper›PMID 40519929›Full record

ArticleFrontiers in immunology2025

Case Report: Multiple peripheral nerve demyelinating lesions and cerebrovascular injury which resulted in extensive cerebral infarction in a XLP1 patient without EBV infection.

Jiaxun Li, Dongcan Mo, Luyu Lv, Fuling Huang, Binyan Wu, Chunjuan He, Hao Wu, Wenpeng Pang, Yan Li, Liping Guo and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiaxun Li *Department of Microbiology, School of Basic Medicine, Guangxi Medical University, Guangxi, Nanning, China.
Dongcan Mo *Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, Nanning, China.
Luyu LvGuangxi Key Laboratory of Thalassemia Research, Guangxi Medical University, Guangxi, Nanning, China.
Fuling HuangDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, Nanning, China.
Binyan WuDepartment of Cardiology, Guigang People's Hospital, Guangxi, Guigang, China.
Chunjuan HeDepartment of Microbiology, School of Basic Medicine, Guangxi Medical University, Guangxi, Nanning, China.
Hao WuDepartment of Microbiology, School of Basic Medicine, Guangxi Medical University, Guangxi, Nanning, China.
Wenpeng PangDepartment of Microbiology, School of Basic Medicine, Guangxi Medical University, Guangxi, Nanning, China.
Yan LiDepartment of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, Nanning, China.
Liping GuoDepartment of Microbiology, School of Basic Medicine, Guangxi Medical University, Guangxi, Nanning, China.
Man LuoDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-linked lymphocytic proliferative disease type 1 (XLP1) is a primary immune deficiency caused by genetic alterations in the

Indexed as

Cerebral InfarctionDemyelinating DiseasesLymphoproliferative DisordersAdolescentEpstein-Barr Virus InfectionsHumansMalecase reportcerebral infarctionmultiple peripheral nerve demyelinating lesionsSH2D1A geneX-linked lymphoproliferative syndrome type 1

Identifiers

PMID40519929
PMCPMC12162628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.